Impact of Dupilumab and Upadacitinib Treatment on Epigenetic and Transcriptomic Alterations in Skin‐Homing T Cells of Atopic Dermatitis Patients
Clinical & Experimental Allergy · 2026-11 · 56 (11) · 1452-1455
DOI: 10.1111/cea.70397 ↗At a glance
Journal article in Clinical & Experimental Allergy, published online on 2026-07-15. Written by Ahmed M I Elfiky and 7 co-authors. Institution: Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. 8 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Health~Holland, the Top Sector Life Sciences & Health.
Abstract (original language)
Skin‐homing T‐helper cells show a unique DNA methylome in AD. Dupilumab partially corrects, whereas upadacitinib broadens methylation differences and reinforces AD‐related methylation signatures.
Authors and institutions
- Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
- Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
- Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
ORCID profiles: Ahmed M I Elfiky, Hidde M Smits, Coco Dekkers, Celeste M Boesjes, Julia Drylewicz, Marjolein de Bruin-Weller
Funding
- Health~Holland, the Top Sector Life Sciences & Health
Cite
APA
Elfiky, A. M. I., Smits, H. M., van der Wal, M., Dekkers, C., Boesjes, C. M., Drylewicz, J., de Bruin-Weller, M., & van Wijk, F. (2026). Impact of Dupilumab and Upadacitinib Treatment on Epigenetic and Transcriptomic Alterations in Skin‐Homing T Cells of Atopic Dermatitis Patients. Clinical & Experimental Allergy, 56(11), 1452-1455. https://doi.org/10.1111/cea.70397
Vancouver
Elfiky AMI, Smits HM, van der Wal M, Dekkers C, Boesjes CM, Drylewicz J, et al. Impact of Dupilumab and Upadacitinib Treatment on Epigenetic and Transcriptomic Alterations in Skin‐Homing T Cells of Atopic Dermatitis Patients. Clinical & Experimental Allergy. 2026;56(11):1452-1455. doi:10.1111/cea.70397
BibTeX
@article{Elfiky2026,
author = {Elfiky, Ahmed M I and Smits, Hidde M and van der Wal, Marlot and Dekkers, Coco and Boesjes, Celeste M and Drylewicz, Julia and de Bruin-Weller, Marjolein and van Wijk, Femke},
title = {Impact of Dupilumab and Upadacitinib Treatment on Epigenetic and Transcriptomic Alterations in Skin‐Homing T Cells of Atopic Dermatitis Patients},
journal = {Clinical & Experimental Allergy},
year = {2026},
volume = {56},
number = {11},
pages = {1452--1455},
doi = {10.1111/cea.70397}
}
EUVIMED